News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
654,303 Results
Type
Article (51223)
Company Profile (150)
Press Release (602916)
Multimedia
Podcasts (170)
Webinars (30)
Section
Business (181176)
Career Advice (1992)
Deals (29798)
Drug Delivery (140)
Drug Development (81926)
Employer Resources (124)
FDA (17130)
Job Trends (12928)
News (318441)
Policy (33338)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2493)
Academic (2)
Accelerated approval (41)
Adcomms (35)
Allergies (151)
Alliances (48063)
ALS (190)
Alzheimer's disease (1743)
Antibody-drug conjugate (ADC) (381)
Approvals (17348)
Artificial intelligence (599)
Autoimmune disease (186)
Automation (42)
Bankruptcy (262)
Best Places to Work (9997)
BIOSECURE Act (22)
Biosimilars (201)
Biotechnology (108)
Bladder cancer (173)
Brain cancer (67)
Breast cancer (646)
Cancer (5066)
Cardiovascular disease (446)
Career advice (1710)
Career pathing (39)
CAR-T (283)
CDC (41)
Celiac Disease (1)
Cell therapy (774)
Cervical cancer (38)
Clinical research (70184)
Collaboration (1883)
Company closure (6)
Compensation (872)
Complete response letters (78)
COVID-19 (2622)
CRISPR (96)
C-suite (873)
Cystic fibrosis (148)
Data (6528)
Decentralized trials (2)
Denatured (57)
Depression (161)
Diabetes (530)
Diagnostics (5792)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (38)
Drug discovery (311)
Drug pricing (226)
Drug shortages (36)
Duchenne muscular dystrophy (244)
Earnings (75884)
Editorial (64)
Employer branding (16)
Employer resources (113)
Events (100087)
Executive appointments (970)
FDA (20425)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1490)
Gene editing (203)
Generative AI (57)
Gene therapy (636)
GLP-1 (1109)
Government (4605)
Grass and pollen (6)
Guidances (370)
Healthcare (16224)
HIV (73)
Huntington's disease (49)
IgA nephropathy (87)
Immunology and inflammation (279)
Immuno-oncology (70)
Indications (128)
Infectious disease (2890)
Inflammatory bowel disease (209)
Inflation Reduction Act (17)
Influenza (113)
Intellectual property (254)
Interviews (362)
IPO (13461)
IRA (61)
Job creations (3278)
Job search strategy (1423)
JPM (65)
Kidney cancer (19)
Labor market (72)
Layoffs (559)
Leadership (36)
Legal (7644)
Liver cancer (97)
Longevity (17)
Lung cancer (683)
Lymphoma (391)
Machine learning (45)
Management (41)
Manufacturing (843)
MASH (176)
Medical device (11279)
Medtech (11332)
Mergers & acquisitions (17381)
Metabolic disorders (1412)
mRNA (160)
Multiple sclerosis (177)
NASH (20)
Neurodegenerative disease (370)
Neuropsychiatric disorders (105)
Neuroscience (3124)
Neurotech (1)
NextGen: Class of 2026 (5482)
Non-profit (3934)
Now hiring (40)
Obesity (694)
Opinion (336)
Ovarian cancer (166)
Pain (216)
Pancreatic cancer (231)
Parkinson's disease (310)
Partnered (29)
Patents (501)
Patient recruitment (526)
Peanut (55)
People (53693)
Pharmaceutical (38)
Pharmacy benefit managers (33)
Phase 1 (21454)
Phase 2 (30351)
Phase 3 (23563)
Pipeline (5984)
Policy (334)
Postmarket research (3134)
Preclinical (9211)
Press Release (67)
Prostate cancer (265)
Psychedelics (59)
Radiopharmaceuticals (292)
Rare diseases (949)
Real estate (4935)
Recruiting (51)
Regulatory (25893)
Reports (37)
Research institute (2351)
Resumes & cover letters (301)
Rett syndrome (31)
RNA editing (13)
RSV (67)
Schizophrenia (160)
Series A (255)
Series B (182)
Service/supplier (9)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (40)
Startups (3261)
State (2)
Stomach cancer (20)
Supply chain (108)
Tariffs (95)
The Weekly (111)
Vaccines (983)
Venture capital (90)
Weight loss (470)
Women's health (89)
Worklife (17)
Date
Today (28)
Last 7 days (683)
Last 30 days (2817)
Last 365 days (29300)
2026 (5434)
2025 (29577)
2024 (32882)
2023 (36576)
2022 (47126)
2021 (50262)
2020 (48075)
2019 (41002)
2018 (31065)
2017 (30362)
2016 (29511)
2015 (33906)
2014 (27838)
2013 (23896)
2012 (25069)
2011 (25505)
2010 (24302)
Location
Africa (842)
Alabama (91)
Alaska (6)
Arizona (223)
Arkansas (14)
Asia (43608)
Australia (6941)
California (10911)
Canada (3125)
China (1192)
Colorado (442)
Connecticut (490)
Delaware (340)
Europe (91518)
Florida (1631)
Georgia (350)
Hawaii (3)
Idaho (43)
Illinois (852)
India (80)
Indiana (494)
Iowa (22)
Japan (466)
Kansas (121)
Kentucky (42)
Louisiana (28)
Maine (47)
Maryland (1355)
Massachusetts (7978)
Michigan (304)
Minnesota (545)
Mississippi (5)
Missouri (118)
Montana (29)
Nebraska (26)
Nevada (120)
New Hampshire (63)
New Jersey (3072)
New Mexico (28)
New York (2946)
North Carolina (1437)
North Dakota (10)
Northern California (5313)
Ohio (310)
Oklahoma (21)
Oregon (36)
Pennsylvania (2134)
Puerto Rico (21)
Rhode Island (49)
South America (1110)
South Carolina (47)
South Dakota (1)
Southern California (4344)
Tennessee (172)
Texas (1721)
United States (38969)
Utah (313)
Vermont (1)
Virginia (273)
Washington D.C. (81)
Washington State (928)
West Virginia (3)
Wisconsin (122)
Wyoming (2)
654,303 Results for "hunan tigermed xiangya drug r and d ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Cashing In on ‘Creative Fundamentals’ To Fund Rare Disease R&D
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations. Initiatives like the Orphan Therapeutics Accelerator are attempting to solve what CEO Craig Martin says is not a science problem, but a math problem.
February 25, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
February 23, 2026
·
4 min read
Press Releases
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference
January 14, 2026
·
6 min read
Press Releases
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
October 17, 2025
·
3 min read
Press Releases
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
February 19, 2026
·
2 min read
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
Press Releases
Immunocore announces R&D leadership evolution
February 1, 2026
·
6 min read
Press Releases
Tigermed Completes Acquisition of Japanese CRO Micron
July 29, 2025
·
3 min read
Press Releases
Calico Appoints Joseph R. Arron, M.D., Ph.D., as Head of Human Biology and Genetics
February 5, 2026
·
3 min read
Drug Pricing
Opinion: Pricing Transparency Is Coming to the Pharma Industry
Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.
February 2, 2026
·
5 min read
·
Joshua R. Mansbach
1 of 65,431
Next
